Table 2.
Descriptive Statistics: Patient Characteristics and Prescribed Therapy in Patients With Normal/Reduced Physical and Mental Components
| Parameter | Patients With a Normal Physical Component n = 40 |
Patients With a Reduced Physical Component n = 85 |
p Value | Patients With a Normal Mental Component n = 65 |
Patients With a Reduced Mental Component n = 60 |
p Value |
|---|---|---|---|---|---|---|
| Medical and demographic parameters | ||||||
| Sex, female | 8 (20.0%) | 43 (50.6%) | 0.002 | 27 (41.5%) | 24 (40.0%) | 0.9 |
| Age, y | 50.0 (IQR: 40.3-58.0) | 58.0 (IQR: 51.0-65.5) | <0.001 | 54.0 (IQR: 48.5-62.0) | 57.0 (IQR: 48.0-66.0) | 0.2 |
| Body mass index, kg/m2 | 28.1 (IQR: 25.1-31.8) | 28.0 (IQR: 25.2-36.8) | 0.8 | 29.4 (IQR: 27.0-37.6) | 26.0 (IQR: 24.5-32.5) | 0.013 |
| Mechanical ventilation | 2 (5.0%) | 5 (5.9%) | 0.9 | 3 (4.6%) | 4 (6.7%) | 0.7 |
| Characteristics of the severity of the condition on admission | ||||||
| SOFA, score | 1.0 (IQR: 1.0-2.0) | 1.0 (IQR: 1.0-2.0) | 0.9 | 1.0 (IQR: 1.0-2.0) | 1.5 (IQR: 1.0-2.0) | 0.6 |
| NEWS, score | 7.0 (IQR: 5.0-8.0) | 7.0 (IQR: 5.0-8.0) | 0.7 | 7.0 (IQR: 5.0-9.0) | 7 (IQR: 5.0-8.0) | 0.4 |
| CT, no involvement | 3 (7.5%) | 11 (12.9%) | 0.5 | 5 (7.7%) | 9 (15.0%) | 0.3 |
| CT, 1-25% involvement | 3 (7.5%) | 5 (5.9%) | 0.7 | 6 (9.2%) | 2 (3.3%) | 0.3 |
| CT, 26-49% involvement | 11 (27.5%) | 20 (23.5%) | 0.7 | 18 (27.7%) | 13 (21.7%) | 0.5 |
| CT, 50-75% involvement | 19 (47.5%) | 40 (47.1%) | 0.9 | 30 (46.2%) | 29 (48.3%) | 0.9 |
| CT, 76-100% involvement | 4 (10.0%) | 9 (10.6%) | 0.9 | 6 (9.2%) | 7 (11.7%) | 0.8 |
| Length of stay, d | ||||||
| Intensive care unit stay | 4.5 (IQR: 3.0-7.0) | 5.0 (IQR: 3.0-7.0) | 0.9 | 5.0 (IQR: 3.0-7.0) | 4.0 (IQR: 3.0-7.0) | 0.7 |
| Hospital stay | 16.0 (IQR: 12.3-18.0) | 16.0 (IQR: 12.0-22.5) | 0.7 | 16.0 (IQR: 13.0-19.5) | 17.0 (IQR: 12.0-22.8) | 0.7 |
| Prescribed therapy | ||||||
| Enoxaparin | 29 (72.5%) | 44 (51.8%) | 0.03 | 42 (64.6%) | 31 (51.7%) | 0.2 |
| Unfractionated Heparin | 9 (22.5%) | 27 (31.8%) | 0.4 | 20 (30.8%) | 16 (26.7%) | 0.7 |
| Tocilizumab | 17 (42.5%) | 31 (36.5%) | 0.6 | 26 (40.0%) | 22 (36.7%) | 0.7 |
| Hydroxychloroquine | 28 (70.0%) | 56 (65.9%) | 0.7 | 50 (76.9%) | 34 (56.7%) | 0.022 |
| Antiviral therapy | 14 (35.0%) | 27 (31.8%) | 0.8 | 23 (35.4%) | 18 (30.0%) | 0.6 |
Abbreviations: CT, computed tomography; IQR, interquartile range; NEWS, National Early Warning Score; SOFA, Sequential Organ Failure Assessment.